Research Output per year
Fingerprint Dive into the research topics where Joshua Davis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 31 Similar Profiles
Northern Territory
Medicine & Life Sciences
Sepsis
Medicine & Life Sciences
Anti-Bacterial Agents
Medicine & Life Sciences
Infection
Medicine & Life Sciences
Lactams
Medicine & Life Sciences
Methicillin-Resistant Staphylococcus aureus
Medicine & Life Sciences
Randomized Controlled Trials
Medicine & Life Sciences
Staphylococcus aureus
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2003 2019
Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal
Campbell, A. J., Dotel, R., Blyth, C. C., Davis, J. S., Tong, S. Y. C. & Bowen, A. C., 1 Jan 2019, In : The Journal of antimicrobial chemotherapy. 74, 1, p. 1-5 5 p.Research output: Contribution to journal › Article › Research › peer-review
Protein Synthesis Inhibitors
Staphylococcus aureus
Anti-Bacterial Agents
Exotoxins
Infection
A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III
Lipman, J., Brett, S. J., De Waele, J. J., Cotta, M. O., Davis, J. S., Finfer, S., Glass, P., Knowles, S., McGuinness, S., Myburgh, J., Paterson, D. L., Peake, S., Rajbhandari, D., Rhodes, A., Roberts, J. A., Shirwadkar, C., Starr, T., Taylor, C., Billot, L. & Dulhunty, J. M., 1 Mar 2019, In : Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 21, 1, p. 63-68 6 p.Research output: Contribution to journal › Article › Research › peer-review
Lactams
Critical Illness
Sepsis
Randomized Controlled Trials
Random Allocation
CASSETTE-clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: Study protocol for a randomised controlled trial
Dotel, R., Tong, S. Y. C., Bowen, A., Nelson, J. N., O'sullivan, M. V. N., Campbell, A. J., McMullan, B. J., Britton, P. N., Francis, J. R., Eisen, D. P., Robinson, O., Manning, L. & Davis, J. S., 13 Jun 2019, In : Trials. 20, 1, p. 1-13 13 p., 353.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Clindamycin
Staphylococcus aureus
Randomized Controlled Trials
Exotoxins
Infection
1
Downloads
(Pure)
Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia
Weis, S., Kesselmeier, M., Davis, J. S., Morris, A. M., Lee, S., Scherag, A., Hagel, S. & Pletz, M. W., Jul 2019, In : Clinical Microbiology and Infection. 25, 7, p. 818-827 10 p.Research output: Contribution to journal › Review article › Research › peer-review
Open Access
File
Cefazolin
Bacteremia
Penicillins
Staphylococcus aureus
Methicillin
Duration of therapy recommended for bacteraemic illness varies widely amongst clinicians
Alwan, M., Davis, J. S., Daneman, N., Fowler, R., Shehabi, Y. & Rogers, B., 11 May 2019, In : International Journal of Antimicrobial Agents. p. 1-5 5 p.Research output: Contribution to journal › Article › Research › peer-review
Communicable Diseases
Therapeutics
Anti-Bacterial Agents
Physicians
New Zealand